peripheral arterial disease

Perception and acceptability of open versus endovascular treatment of common femoral artery disease: barriers and facilitators for randomised controlled trials

July 21, 2023

Introduction The standard of care for the treatment of atherosclerotic disease of the common femoral artery (CFA) remains open surgical CFA endarterectomy (CFAE). Endovascular interventions, however, have become first-line therapies for atherosclerotic disease of other arterial segments. This is due to their minimally invasive nature, low rates of perioperative complications and patient preference.1–4 High rates […]

Read More

Distal venous arterialisation for ‘no-option’ chronic limb-threatening ischaemia

March 29, 2022

Abstract Chronic limb-threatening ischaemia (CLTI), defined as significant peripheral arterial disease causing ischaemic rest pain and/or tissue loss, is associated with a high amputation and mortality rate. Avoiding amputation in CLTI is crucial and restoration of blood flow is usually achieved using endovascular or open surgical revascularisation. However, significant occlusion of the distal limb vasculature […]

Read More

The Vascular PAD-QIF CQUIN: what is it, why is it important, what does it mean for vascular units?

March 29, 2022

The Commissioning for Quality and Innovation (CQUIN) indicators for 2022/23 were recently published by NHS England and for the first time include a vascular indicator, the “Achievement of revascularisation standards for lower limb ischaemia”.1 This is great news and will drive quality improvement for patients with chronic limb-threatening ischaemia (CLTI). In this editorial we describe […]

Read More

Research priorities for patients with peripheral arterial disease: a James Lind Alliance Priority Setting Partnership

February 11, 2022

Introduction Peripheral arterial disease (PAD) is an atherosclerotic process whereby the arteries supplying the lower limbs become narrowed or occluded. PAD is an increasingly common disease, estimated to affect 237 million people, with an increase of 45% between 2000 and 2015.1,2 The PAD spectrum is wide and ranges from asymptomatic, whereby the patient is often […]

Read More